NCT07207174 Brief Mindfulness-Oriented Recovery Enhancement vs Brief Cognitive-Behavioral Therapy for Chronic Pain
| NCT ID | NCT07207174 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Florida State University |
| Condition | Chronic Pain |
| Study Type | INTERVENTIONAL |
| Enrollment | 120 participants |
| Start Date | 2025-09-26 |
| Primary Completion | 2027-09-22 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 120 participants in total. It began in 2025-09-26 with a primary completion date of 2027-09-22.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This randomized controlled trial aims to test both English and Spanish versions of two, benign behavioral interventions for adults with chronic pain -- 1) Brief Mindfulness-Oriented Recovery Enhancement (B-MORE), and 2) Brief Cognitive- Behavioral Therapy (B-CBT).
Eligibility Criteria
Inclusion Criteria: * Having a chronic pain condition * Average pain of \> 3 in the last week * Willingness to engage with study assessments and interventions * Understanding English or Spanish instructions fluently * Age 18 and above. Exclusion Criteria: * Unable to consent because of physical or mental incapacity * Have previous, formal mindfulness or CBT training (e.g., MBSR) * Have pain from a current cancer diagnosis * Unstable illness that may interfere with treatment * Had surgery within the previous three months * Had pain relieving injections, such as cortisone or hyaluronate, within the previous three months.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07207174 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Chronic Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07207174 currently recruiting?
Yes, NCT07207174 is actively recruiting participants. Contact the research team at adam.hanley@fsu.edu for enrollment information.
Where is the NCT07207174 trial being conducted?
This trial is being conducted at Tallahassee, United States.
Who is sponsoring the NCT07207174 clinical trial?
NCT07207174 is sponsored by Florida State University. The trial plans to enroll 120 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.